Edgewise Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Edgewise Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
Edgewise Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 2.6K %, a 7.51% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	2.6K	+182	+7.51%	Jun 30, 2024
Q1 2024	2.39K	-147	-5.8%	Mar 31, 2024
Q4 2023	2.12K	-426	-16.7%	Dec 31, 2023
Q3 2023	2.17K	-558	-20.4%	Sep 30, 2023
Q2 2023	2.42K	-438	-15.4%	Jun 30, 2023
Q1 2023	2.54K	-654	-20.5%	Mar 31, 2023
Q4 2022	2.54K	-1.31K	-34.1%	Dec 31, 2022
Q3 2022	2.73K	-1.47K	-34.9%	Sep 30, 2022
Q2 2022	2.85K			Jun 30, 2022
Q1 2022	3.19K			Mar 31, 2022
Q4 2021	3.86K			Dec 31, 2021
Q3 2021	4.2K			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.